| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10035696 | HBV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30008074 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30080228 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30074792 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30018495 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30054612 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30054613 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30054614 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30054615 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
| TVIS30054616 | HIV | ENSG00000159267.17 | protein_coding | HLCS | No | No | 3141 | P50747 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HLCS |
|---|---|
| DrugBank ID | DB00121 |
| Drug Name | Biotin |
| Target ID | BE0000159 |
| UniProt ID | P50747 |
| Regulation Type | substrate |
| PubMed IDs | 16359899; 16772434; 17056793 |
| Citations | Velazquez-Arellano A: From an inborn error patient to a search for regulatory meaning: a biotin conducted voyage. Mol Genet Metab. 2006 Mar;87(3):194-7. Epub 2005 Dec 15.@@Hassan YI, Zempleni J: Epigenetic regulation of chromatin structure and gene function by biotin. J Nutr. 2006 Jul;136(7):1763-5.@@Camporeale G, Giordano E, Rendina R, Zempleni J, Eissenberg JC: Drosophila melanogaster holocarboxylase synthetase is a chromosomal protein required for normal histone biotinylation, gene transcription patterns, lifespan, and heat tolerance. J Nutr. 2006 Nov;136(11):2735-42. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | Biotin and derivatives |
| SMILES | [H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2 |
| Pathways | Mitochondrial Complex II Deficiency; 3-Methylglutaconic Aciduria Type III; 2-Ketoglutarate Dehydrogenase Complex Deficiency; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Isovaleric Aciduria; Pyruvate Carboxylase Deficiency; Warburg Effect; Isobutyryl-CoA Dehydrogenase Deficiency; Biotin Metabolism; Fructose-1,6-diphosphatase Deficiency; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Propionic Acidemia; Transfer of Acetyl Groups into Mitochondria; Malonic Aciduria; 2-Hydroxyglutric Aciduria (D and L Form); 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Congenital Lactic Acidosis; 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency; Fumarase Deficiency; Succinic Semialdehyde Dehydrogenase Deficiency; Alanine Metabolism; Methylmalonic Aciduria; 3-Methylglutaconic Aciduria Type IV; Lactic Acidemia; Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease; Primary Hyperoxaluria Type I; Triosephosphate Isomerase; The Oncogenic Action of 2-Hydroxyglutarate; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease |
| PharmGKB | PA448625 |
| ChEMBL | CHEMBL857 |
